Clinical Trials Browser

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Head and Neck Neoplasms, Kidney Neoplasms, Mesothelioma, Ovarian Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT07061769 2025-07-11

Helping Cancer Patients Manage Neuropathy Symptoms From Chemotherapy With a Low-Intensity, Low-Risk Cranial PEMF Device

Phase NA Enrolling by invitation

50 enrolled

Chemotherapy Induced Peripheral Neuropathy

NCT07053904 2025-07-08

Phase I Open-Label Study of P1101 Followed by P1801 in Advanced Solid Tumors

Phase 1 Enrolling by invitation

54 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT07046832 2025-07-02

Clinical Evaluation of an Augmented Reality Intraprocedural Needle Guidance Platform for Soft Tissue Biopsy

Phase NA Enrolling by invitation

104 enrolled

GastrointestinalGenitourinary

Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Neoplasms

NCT06992687 2025-05-28

A Study to Evaluate the Safety and Efficacy of HB0052 in Patients With Advanced Solid Tumors

Phase 1/2 Enrolling by invitation

30 enrolled

Other solid neoplasm

Solid Tumors

NCT06940648 2025-05-06

VIABLE

Phase NA Enrolling by invitation

30 enrolled

Genitourinary

Urinary Bladder Neoplasms

NCT06925685 2025-04-13

Follow-Up for Study Participants Treated With an Allogeneic CAR T-Cell Product

Enrolling by invitation

50 enrolled

Other hematologic neoplasm

Hematologic Neoplasms

NCT04915495 2025-03-21

The Use of the LuViva Advanced Cervical Scan to Identify Women at High-Risk for Cervical Neoplasia

Phase NA Enrolling by invitation

400 enrolled

Gynecologic

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT04145375 2025-03-19

Continuation Protocol for ZEN003694 in Patients Experiencing Clinical Benefit While Enrolled in a ZEN003694 Protocol

Phase 1/2 Enrolling by invitation

40 enrolled

Genitourinary

Prostatic Neoplasms

NCT06157671 2025-03-07

The LINFU® U.S. Registry for the Detection of Asymptomatic Pancreatic Ductal Adenocarcinoma

Enrolling by invitation

1,000 enrolled

Gastrointestinal

Pancreatic Adenocarcinoma

NCT06276764 2025-03-07

The LINFU® U.S. Registry in Patients With IPMN (Intraductal Papillary Mucinous Neoplasm of the Pancreas)

Enrolling by invitation

500 enrolled

Gastrointestinal

Pancreatic Intraductal Neoplasms, Pancreatic Cyst, Pancreatic Neoplasms

NCT06709040 2025-02-05

A Study to Follow Paediatric Participants With Growth Hormone Deficiency Treated With Somapacitan for Long Term Safety Information and Clinical Parameters

Enrolling by invitation

500 enrolled

Endocrine

Diabetes Mellitus, Type 2, Dwarfism, Pituitary, Neoplasms

NCT03328026 2025-02-04

Combination Study of SV-BR-1-GM With Retifanlimab

Phase 1/2 Enrolling by invitation

36 enrolled

Breast

Breast Neoplasms

Clinical Trials

Development and Application of Patient-Derived Models of Cancer

Study of Tislelizumab, Pamiparib, and Other Investigational Agents in Participants With Advanced Malignancies

PERSIST

ziMyG+

LTFS

Futibatinib in Patients Previously Enrolled in an Antecedent Futibatinib as Monotherapy or Combination Therapy.

An Extension Study Evaluating 6-week Treatment Cycles of Rozanolixizumab in Pediatric Study Participants With Generalized Myasthenia Gravis

Long-term Follow-up Study for Participants of Kite-Sponsored Interventional Studies Treated With Gene-Modified Cells

NOECHO

ROSY-D

SAFE-3CV

RESTORE LB

A Long-Term Follow-Up Basket Study for Participants Treated With SynKIR Chimeric Antigen Receptor (CAR) T Cell Product

ADAPT Jr +

A Study of HB0025 Plus Nab-paclitaxel as First Line Therapy for TNBC

Safety Extension Study for Subjects With HR+, HER2- Breast Cancer for Subjects Who Have Completed the OVELIA Study

A Study to Learn About the Long-Term Health of Adult Participants From a Previous Study of a New Melanoma Treatment

GYNORYLAQ™

Posterior Cervical Fixation Study

KANNON-2

A Clinical Study Evaluating the Safety and Efficacy of BioTTT001 in Patients With Recurrent/Progressive High-grade Glioma.

A Clinical Study Evaluating the Safety and Efficacy of BioTTT001 in Patients With Malignant Solid Tumors

Using CICS-1 and SPM-011 and ［18F］FBPA Commissioned by CICS and Sumitomo Heavy Industries and STELLA PHARMA

RegisterNET

A Study for Participants Who Participated in Prior Clinical Studies of ASTX727 (Standard Dose)

Long-term Follow-up of Gene Therapy for Radiation-Induced Xerostomia

A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring

Study of HuL001 in Relapsed/Refractory Multiple Myeloma Patients

Study of ZV0203 in Patients With HER2-Positive Advanced Solid Tumors

Clinical Study of a Novel Oncolytic Virus Ad-TD-nsIL12 in the Treatment of Primary High-grade Glioma

Clinical Trial to Treat Stage IV Cancer Patients

HTK_002

XS-03-II201

A Long-term Follow-up Study of Subjects Who Received CRISPR CAR T Cellular Therapies

Long-term Follow-up of Patients Treated With Genetically Modified Autologous T Cells

BrainMets AI

K-ACCELERATE

DESCENT-1

Helping Cancer Patients Manage Neuropathy Symptoms From Chemotherapy With a Low-Intensity, Low-Risk Cranial PEMF Device

Phase I Open-Label Study of P1101 Followed by P1801 in Advanced Solid Tumors

Clinical Evaluation of an Augmented Reality Intraprocedural Needle Guidance Platform for Soft Tissue Biopsy

A Study to Evaluate the Safety and Efficacy of HB0052 in Patients With Advanced Solid Tumors

VIABLE

Follow-Up for Study Participants Treated With an Allogeneic CAR T-Cell Product

The Use of the LuViva Advanced Cervical Scan to Identify Women at High-Risk for Cervical Neoplasia

Continuation Protocol for ZEN003694 in Patients Experiencing Clinical Benefit While Enrolled in a ZEN003694 Protocol

The LINFU® U.S. Registry for the Detection of Asymptomatic Pancreatic Ductal Adenocarcinoma

The LINFU® U.S. Registry in Patients With IPMN (Intraductal Papillary Mucinous Neoplasm of the Pancreas)

A Study to Follow Paediatric Participants With Growth Hormone Deficiency Treated With Somapacitan for Long Term Safety Information and Clinical Parameters

Combination Study of SV-BR-1-GM With Retifanlimab